To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLTMTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
511 supporting clones for gene SLTM back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AA436082   SLTM.a 1 to 318 11 to 337       327/341
(95 %)
25 diff
(92.7 %id)
BF002209 colon, colon tumor, RER+ SLTM.a 17 to 500 481 to 1   tiling clone,   481/481
(100 %)
2 diff
(99.6 %id)
AI524734 B-cell, chronic lymphotic leukemia SLTM.a 53 to 475 420 to 1       420/420
(100 %)
1 diff
(99.8 %id)
AI625800 Kidney SLTM.a 80 to 475 393 to 1   tiling clone,   393/393
(100 %)
1 diff
(99.8 %id)
AI739647 colon, colon tumor, RER+ SLTM.a 230 to 475 244 to 1       244/244
(100 %)
3 diff
(98.8 %id)
NM_024755.2   SLTM.a 493 to 4638 1 to 4146   RefSeq, AAA   4146/4146
(100 %)
0 diff
(100 %id)
BC140851 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones SLTM.a 503 to 3925 1 to 3423   tiling clone,   3423/3423
(100 %)
0 diff
(100 %id)
BF529187 anaplastic oligodendroglioma with 1p/19qloss, brain SLTM.a 538 to 1332 1 to 786       786/986
(79 %)
17 diff
(98.3 %id)
DA738408   SLTM.a 547 to 1420 2 to 882   capped   881/882
(99 %)
19 diff
(97.9 %id)
CN370460 embryonic stem cells, cell lines H1, H7, andH9 SLTM.a 555 to 1215 2 to 662       661/662
(99 %)
5 diff
(99.3 %id)
DR001794 fetal brain SLTM.a 558 to 1223 8 to 674       667/674
(98 %)
7 diff
(99.0 %id)
BC108656 Testis, embryonal carcinoma SLTM.a 559 to 1687 14 to 1142   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1129/1132
(99 %)
5 diff
(99.6 %id)
BG387655 embryonal carcinoma, cell line, testis SLTM.a 559 to 1292 12 to 742       731/826
(88 %)
13 diff
(98.5 %id)
BG756820 B-cells, primary B-cells from tonsils (cell line) SLTM.a 559 to 1265 1 to 706       706/706
(100 %)
3 diff
(99.6 %id)
CD684408 normal nasopharynx SLTM.a 565 to 1195 24 to 654       631/654
(96 %)
13 diff
(98.1 %id)
BG506037 embryonal carcinoma, testis SLTM.a 569 to 1285 1 to 722       720/729
(98 %)
22 diff
(97.0 %id)
AK000867 whole embryo, mainly head SLTM.a 578 to 2111 1 to 1534   available from FLJ,   1534/1535
(99 %)
2 diff
(99.9 %id)
AU116864 whole embryo, mainly head SLTM.a 579 to 1311 2 to 738   capped   737/743
(99 %)
10 diff
(98.7 %id)
CN370461 embryonic stem cells, cell lines H1, H7, andH9 SLTM.a 589 to 1302 1 to 714       714/714
(100 %)
5 diff
(99.3 %id)
BE794224 lung, small cell carcinoma SLTM.a 590 to 1404 1 to 803       803/946
(84 %)
14 diff
(98.6 %id)
BE784020 eye, retinoblastoma SLTM.a 607 to 1387 1 to 778       778/786
(98 %)
17 diff
(97.9 %id)
CN370458 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLTM.a 658 to 1266 1 to 609       609/609
(100 %)
6 diff
(99.1 %id)
CF786058 mixed SLTM.a 801 to 1477 1 to 677       677/804
(84 %)
16 diff
(98.1 %id)
BE064626 breast SLTM.a 948 to 1481 21 to 569       549/572
(95 %)
24 diff
(95.9 %id)
BQ214240 large cell carcinoma, lung SLTM.a 983 to 1806 1 to 835       835/902
(92 %)
24 diff
(97.4 %id)
CN289142 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLTM.a 1070 to 1472 1 to 404       404/404
(100 %)
1 diff
(99.8 %id)
CB132594 Liver SLTM.a 1086 to 1534 1 to 449       449/449
(100 %)
0 diff
(100 %id)
TI_1968233499   SLTM.a 1092 to 2176 25 to 1101   AAA   1077/1242
(86 %)
24 diff
(98.1 %id)
BM791523 Ascites, stomach SLTM.a 1092 to 1684 1 to 593       593/593
(100 %)
3 diff
(99.5 %id)
DB082018 testis SLTM.a 1114 to 1632 2 to 521   capped   520/520
(100 %)
1 diff
(99.9 %id)
AK024710   SLTM.a 1157 to 2127 1 to 971   available from FLJ, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 971/972
(99 %)
4 diff
(99.6 %id)
AU143839 whole embryo, mainly head SLTM.a 1654 to 2111 459 to 2       458/461
(99 %)
2 diff
(99.6 %id)
DA215437 brain SLTM.b 1 to 543 2 to 544   tiling clone, capped   543/543
(100 %)
0 diff
(100 %id)
TI_153989272   SLTM.b 19 to 669 43 to 693   AAA Submitted on the opposite strand 651/966
(67 %)
8 diff
(99.2 %id)
BE673776 carcinoid, lung SLTM.b 22 to 524 1 to 503     Submitted on the opposite strand 503/503
(100 %)
1 diff
(99.9 %id)
AI215187 carcinoid, lung SLTM.b 23 to 490 1 to 468     Submitted on the opposite strand 468/468
(100 %)
3 diff
(99.4 %id)
AI373544 Kidney SLTM.b 23 to 517 1 to 492   AAA Submitted on the opposite strand 492/506
(97 %)
5 diff
(99.1 %id)
AW237745 Kidney SLTM.b 23 to 489 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
AW514357 pooled SLTM.b 23 to 525 1 to 503     Submitted on the opposite strand 503/503
(100 %)
2 diff
(99.7 %id)
BF732755 fibrotheoma, ovary SLTM.b 23 to 424 1 to 402     Submitted on the opposite strand 402/402
(100 %)
0 diff
(100 %id)
BF058068 fibrotheoma, ovary SLTM.b 23 to 426 1 to 404     Submitted on the opposite strand 404/414
(97 %)
1 diff
(99.8 %id)
NM_001013843.1   SLTM.b 23 to 4114 1 to 4092 exact RefSeq, AAA   4092/4092
(100 %)
0 diff
(100 %id)
AA902161 pooled germ cell tumors SLTM.b 24 to 355 1 to 331     Submitted on the opposite strand 331/331
(100 %)
11 diff
(96.7 %id)
AW205376   SLTM.b 24 to 669 1 to 646     Submitted on the opposite strand 646/656
(98 %)
2 diff
(99.7 %id)
BF852996 lung_normal SLTM.b 28 to 487 1 to 459       459/462
(99 %)
6 diff
(98.8 %id)
CN370459 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SLTM.b 32 to 317 1 to 286       286/286
(100 %)
2 diff
(99.4 %id)
TI_1968231213   SLTM.b 33 to 702 47 to 716       670/1288
(52 %)
8 diff
(99.4 %id)
DW420477 Liver SLTM.b 34 to 323 10 to 300       291/300
(97 %)
6 diff
(98.0 %id)
AI523544 B-cell, chronic lymphotic leukemia SLTM.b 41 to 493 1 to 453     Submitted on the opposite strand 453/453
(100 %)
1 diff
(99.8 %id)
CF993817 Human Placenta, placenta SLTM.b 42 to 522 29 to 513       485/1179
(41 %)
27 diff
(97.8 %id)
DA719738   SLTM.b 44 to 611 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB279732 uterus SLTM.b 47 to 598 2 to 561   capped   560/560
(100 %)
8 diff
(98.6 %id)
DW447363 Liver SLTM.b 70 to 271 11 to 213       203/213
(95 %)
6 diff
(97.2 %id)
DA255881 caudate nucleus SLTM.b 73 to 637 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA551218   SLTM.b 73 to 594 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
BU532328 mixed (pool of 40 RNAs) SLTM.b 74 to 585 1 to 512       512/513
(99 %)
4 diff
(99.3 %id)
DA398493 thalamus SLTM.b 75 to 624 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA216119 brain SLTM.b 76 to 599 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
BF590511 colon, colon tumor, RER+ SLTM.b 76 to 500 425 to 1       425/425
(100 %)
0 diff
(100 %id)
BF977037 melanotic melanoma, high MDR, skin SLTM.b 76 to 629 1 to 551       551/898
(61 %)
16 diff
(98.3 %id)
DA821160 pericardium SLTM.b 76 to 631 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA112824 cerebellum SLTM.b 77 to 613 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BM843434 lymph node, stomach SLTM.b 77 to 578 1 to 502       502/502
(100 %)
0 diff
(100 %id)
DA968687 stomach SLTM.b 77 to 621 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DB014444 esophageal, tumor tissue SLTM.b 77 to 615 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA457363 tongue, tumor tissue SLTM.b 78 to 641 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA460089 tongue, tumor tissue SLTM.b 78 to 628 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB277794 uterus SLTM.b 78 to 609 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DW462470 Liver SLTM.b 84 to 426 18 to 361       344/368
(93 %)
11 diff
(97.1 %id)
BX488721   SLTM.b 88 to 627 1 to 540       540/540
(100 %)
1 diff
(99.9 %id)
CD686585 normal nasopharynx SLTM.b 89 to 653 14 to 578       565/578
(97 %)
8 diff
(98.7 %id)
DW453866 Liver SLTM.b 89 to 255 18 to 184       167/184
(90 %)
6 diff
(96.8 %id)
BG341538 B-cells, primary B-cells from tonsils (cell line) SLTM.b 89 to 808 1 to 785       735/880
(83 %)
35 diff
(96.1 %id)
DW466724 Liver SLTM.b 93 to 426 11 to 344       334/350
(95 %)
8 diff
(97.8 %id)
BX472347   SLTM.b 95 to 621 1 to 527       527/527
(100 %)
6 diff
(98.9 %id)
DW437520 Liver SLTM.b 95 to 332 11 to 248       238/248
(95 %)
6 diff
(97.6 %id)
DB088021 testis SLTM.b 96 to 648 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA569209 whole embryo, mainly head SLTM.b 98 to 968 2 to 873   tiling clone, fully sequenced, capped   872/872
(100 %)
8 diff
(99.1 %id)
CN370457 embryonic stem cells, cell lines H1, H7, andH9 SLTM.b 104 to 648 1 to 545       545/545
(100 %)
2 diff
(99.7 %id)
DB216018 trachea SLTM.b 108 to 658 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
N52621 multiple sclerosis lesions SLTM.b 109 to 493 1 to 387     Submitted on the opposite strand 387/396
(97 %)
15 diff
(96.3 %id)
AA761705 germinal center B cell SLTM.b 109 to 337 1 to 229     Submitted on the opposite strand 229/230
(99 %)
2 diff
(99.2 %id)
AA909603 pooled SLTM.b 109 to 423 1 to 314     Submitted on the opposite strand 314/314
(100 %)
1 diff
(99.7 %id)
DA992637 synovial membrane tissue from rheumatioidarthritis SLTM.b 109 to 645 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
BF732528 fibrotheoma, ovary SLTM.b 116 to 361 1 to 246     Submitted on the opposite strand 246/286
(86 %)
9 diff
(96.9 %id)
AA333507 Embryo, 8 weeks SLTM.b 117 to 362 3 to 248       246/258
(95 %)
8 diff
(96.9 %id)
AW966102   SLTM.b 117 to 672 2 to 557       556/608
(91 %)
11 diff
(98.2 %id)
AA157163   SLTM.b 118 to 523 1 to 408       408/408
(100 %)
4 diff
(99.1 %id)
CN370462 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLTM.b 120 to 474 1 to 355       355/355
(100 %)
3 diff
(99.2 %id)
CT000998 T-Lymphocytes SLTM.b 135 to 634 1 to 500       500/500
(100 %)
0 diff
(100 %id)
AI473153 Kidney SLTM.b 195 to 501 307 to 1       307/307
(100 %)
0 diff
(100 %id)
TI_153989296   SLTM.b 197 to 669 225 to 698     Submitted on the opposite strand 474/966
(49 %)
10 diff
(99.0 %id)
AA767566 germinal center B cell SLTM.b 225 to 438 1 to 214     Submitted on the opposite strand 214/218
(98 %)
1 diff
(99.6 %id)
AA090692   SLTM.b 306 to 484 1 to 179       179/179
(100 %)
0 diff
(100 %id)
EH313779   SLTM.b 369 to 418 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AW779632 colon, moderately-differentiated adenocarcinoma SLTM.b 385 to 589 205 to 1       205/205
(100 %)
1 diff
(99.6 %id)
CU455117 epidermis SLTM.b 390 to 972 588 to 5     Submitted on the opposite strand 584/590
(98 %)
11 diff
(98.2 %id)
CB134139 Liver SLTM.b 591 to 1204 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
CN289601 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLTM.b 600 to 1152 9 to 561       553/561
(98 %)
6 diff
(99.0 %id)
BI859032 breast, mammary adenocarcinoma, cell line SLTM.b 608 to 1466 1 to 869       869/869
(100 %)
20 diff
(97.7 %id)
TI_57190557   SLTM.b 608 to 1432 90 to 923   AAA   834/852
(97 %)
15 diff
(98.3 %id)
CF136935 lymph SLTM.b 676 to 1009 1 to 334       334/334
(100 %)
16 diff
(95.3 %id)
TI_154166230   SLTM.b 694 to 1158 80 to 555       487/480
(101 %)
58 diff
(88.0 %id)
BM280354 bone marrow, thyroid SLTM.b 742 to 961 264 to 45   AAA   220/253
(86 %)
0 diff
(100 %id)
BM455336 lymph, lymphoma, cell line SLTM.b 754 to 1605 881 to 22     Submitted on the opposite strand 860/1059
(81 %)
15 diff
(98.6 %id)
BU859848 adenocarcinoma, cell line, breast SLTM.b 817 to 1696 1 to 879   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 879/896
(98 %)
10 diff
(98.9 %id)
FN165531 breast carcinoma SLTM.b 839 to 916 1 to 78       78/78
(100 %)
3 diff
(96.2 %id)
BF212449 bone marrow, from chronic myelogenous leukemia SLTM.b 863 to 1436 1 to 576       576/620
(92 %)
7 diff
(98.9 %id)
BI062138 uterus_tumor SLTM.b 883 to 1317 435 to 1       435/435
(100 %)
2 diff
(99.6 %id)
BQ103842   SLTM.b 903 to 1595 21 to 713   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 693/717
(96 %)
7 diff
(99.1 %id)
BQ103843   SLTM.b 903 to 1599 11 to 707   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 697/707
(98 %)
11 diff
(98.5 %id)
AW888876 nervous_tumor SLTM.b 921 to 1283 405 to 43       363/406
(89 %)
8 diff
(98.1 %id)
FN142579 breast carcinoma SLTM.b 929 to 1013 83 to 1     Submitted on the opposite strand 83/84
(98 %)
2 diff
(97.7 %id)
AU144580 whole embryo, mainly head SLTM.b 938 to 1587 642 to 1   fully sequenced,   642/642
(100 %)
17 diff
(97.4 %id)
CB125516 cervix, Uterine SLTM.b 941 to 1558 1 to 618       618/618
(100 %)
1 diff
(99.9 %id)
BG387536 embryonal carcinoma, cell line, testis SLTM.b 944 to 1663 1 to 715       715/715
(100 %)
11 diff
(98.5 %id)
BM715452 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SLTM.b 957 to 1639 1 to 683   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 683/683
(100 %)
7 diff
(99.0 %id)
AA133526 colon, tumor SLTM.b 965 to 1306 45 to 386   fully sequenced,   342/386
(88 %)
6 diff
(98.5 %id)
DB120757 thymus SLTM.b 967 to 1517 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
TI_151776406   SLTM.b 1011 to 1639 171 to 804   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 634/1279
(49 %)
16 diff
(98.8 %id)
AA157075   SLTM.b 1042 to 1459 421 to 1       421/421
(100 %)
3 diff
(99.3 %id)
TI_1968233463   SLTM.b 1052 to 2261 5 to 1197       1155/1284
(89 %)
22 diff
(98.3 %id)
CN259505 embryonic stem cells, cell lines H1, H7, andH9 SLTM.b 1052 to 1677 34 to 659       626/659
(94 %)
6 diff
(99.1 %id)
AW469488 pooled SLTM.b 1113 to 1538 430 to 5       426/433
(98 %)
11 diff
(97.5 %id)
AW973904   SLTM.b 1117 to 1675 559 to 1     Submitted on the opposite strand 559/559
(100 %)
5 diff
(99.2 %id)
BG822478 adenocarcinoma cell line, colon SLTM.b 1142 to 1788 1 to 663   available from MGC,   663/689
(96 %)
34 diff
(95.1 %id)
BC014944 Colon, adenocarcinoma SLTM.b 1143 to 3729 1 to 2587   available from MGC, AAA   2587/2587
(100 %)
1 diff
(100.0 %id)
AA931237 Kidney SLTM.b 1160 to 1676 517 to 1       517/517
(100 %)
0 diff
(100 %id)
BF083252 colon SLTM.b 1173 to 1697 25 to 551       527/551
(95 %)
19 diff
(96.6 %id)
DA435305 tongue, tumor tissue SLTM.b 1173 to 1755 2 to 583   capped   582/583
(99 %)
2 diff
(99.7 %id)
AI270586 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SLTM.b 1173 to 1587 415 to 1       415/415
(100 %)
0 diff
(100 %id)
BF526356 brain, glioblastoma with EGFR amplification SLTM.b 1194 to 1911 1 to 711       711/723
(98 %)
10 diff
(98.7 %id)
AA594603 colon, colon tumor RER+ SLTM.b 1197 to 1675 479 to 1       479/479
(100 %)
3 diff
(99.4 %id)
BU533084 mixed (pool of 40 RNAs) SLTM.b 1208 to 1677 1 to 470       470/504
(93 %)
3 diff
(99.5 %id)
AA625619 whole brain SLTM.b 1209 to 1578 370 to 1       370/370
(100 %)
7 diff
(98.2 %id)
BE180705 head_neck SLTM.b 1250 to 1445 1 to 191       193/191
(101 %)
7 diff
(96.4 %id)
BM673934 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SLTM.b 1253 to 1639 391 to 5   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 387/391
(98 %)
0 diff
(100 %id)
CA429053 Cell Line, Chondrosarcoma SLTM.b 1253 to 1693 441 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 439/634
(69 %)
2 diff
(99.7 %id)
AA133527 colon, tumor SLTM.b 1255 to 1676 422 to 1   fully sequenced,   422/422
(100 %)
0 diff
(100 %id)
BG025116 lymph, lymphoma, cell line SLTM.b 1258 to 1954 1 to 708       611/763
(80 %)
14 diff
(98.2 %id)
AW079646 esophagus, squamous cell carcinoma SLTM.b 1266 to 1588 323 to 1       323/323
(100 %)
5 diff
(98.5 %id)
DW445790 Liver SLTM.b 1282 to 1479 23 to 220       202/220
(91 %)
8 diff
(96.4 %id)
DA573052 whole embryo, mainly body SLTM.b 1282 to 1954 2 to 675   capped   674/676
(99 %)
3 diff
(99.6 %id)
DN997287 breast cancer, Mammary gland (cancer tissue) SLTM.b 1284 to 1896 1 to 613       613/613
(100 %)
5 diff
(99.2 %id)
DW419134 Liver SLTM.b 1289 to 1679 17 to 408       392/408
(96 %)
9 diff
(97.8 %id)
DW446183 Liver SLTM.b 1289 to 1490 17 to 218       202/218
(92 %)
7 diff
(96.8 %id)
BE697458 colon SLTM.b 1297 to 1706 3 to 424       422/484
(87 %)
25 diff
(94.9 %id)
BG896339 cartilage SLTM.b 1311 to 1615 87 to 391       305/322
(94 %)
10 diff
(96.9 %id)
DA814138   SLTM.b 1329 to 1908 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AA574002   SLTM.b 1340 to 1456 116 to 1       116/118
(98 %)
6 diff
(95.0 %id)
CB243660 Human Lung Epithelial cells, lung SLTM.b 1353 to 1693 342 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 340/416
(81 %)
0 diff
(100 %id)
AW134927   SLTM.b 1361 to 1636 18 to 293     Submitted on the opposite strand 276/276
(100 %)
2 diff
(99.3 %id)
TI_149270907   SLTM.b 1376 to 1863 545 to 58   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 488/1068
(45 %)
9 diff
(99.2 %id)
BU674072 lung, Primary Lung Epithelial Cells SLTM.b 1376 to 1847 473 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 472/513
(92 %)
0 diff
(100 %id)
AU253294 neuroblastoma SLTM.b 1434 to 2114 21 to 700       681/700
(97 %)
8 diff
(98.9 %id)
AW996827 breast_normal SLTM.b 1447 to 1896 573 to 122     Submitted on the opposite strand 452/573
(78 %)
1 diff
(99.9 %id)
DB250510 uterus SLTM.b 1474 to 2049 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
BM471745 eye, retinoblastoma SLTM.b 1476 to 1813 367 to 31     Submitted on the opposite strand 337/1235
(27 %)
0 diff
(100 %id)
CB134801 Liver SLTM.b 1484 to 2018 535 to 1     Submitted on the opposite strand 535/535
(100 %)
0 diff
(100 %id)
DA774450 brain SLTM.b 1485 to 2058 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BP249540 Kidney SLTM.b 1491 to 2073 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AK023275   SLTM.b 1492 to 4108 1 to 2617   tiling clone, available from FLJ,   2617/2617
(100 %)
0 diff
(100 %id)
AU133031   SLTM.b 1493 to 2359 2 to 858   capped   857/869
(98 %)
11 diff
(98.8 %id)
BI546180 brain, hippocampus SLTM.b 1494 to 2131 1 to 638       638/638
(100 %)
3 diff
(99.6 %id)
TI_44166274   SLTM.b 1494 to 2131 85 to 722       638/722
(88 %)
6 diff
(99.2 %id)
BP244404 Kidney SLTM.b 1496 to 2117 1 to 619       619/624
(99 %)
27 diff
(95.7 %id)
BF086930 head_neck SLTM.b 1498 to 1882 9 to 397       389/478
(81 %)
14 diff
(97.1 %id)
BU689903 Human Lung Epithelial cells, lung SLTM.b 1509 to 1847 340 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 339/384
(88 %)
0 diff
(100 %id)
BU689674 Human Lung Epithelial cells, lung SLTM.b 1509 to 1847 340 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 339/384
(88 %)
0 diff
(100 %id)
BG958915 colon SLTM.b 1538 to 2044 8 to 525       518/525
(98 %)
27 diff
(94.9 %id)
CA419826 Bone, Human Chondrosarcoma Cell Line SLTM.b 1547 to 1847 302 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 301/302
(99 %)
3 diff
(99.1 %id)
AW352431 stomach SLTM.b 1552 to 2036 1 to 485       485/485
(100 %)
2 diff
(99.6 %id)
AI908571 breast SLTM.b 1560 to 2027 483 to 15       469/483
(97 %)
3 diff
(99.4 %id)
DA488102 brain SLTM.b 1563 to 2106 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
CB163018 Liver SLTM.b 1569 to 2077 508 to 1     Submitted on the opposite strand 508/532
(95 %)
10 diff
(98.2 %id)
CB159076 Liver SLTM.b 1575 to 1821 249 to 3     Submitted on the opposite strand 247/249
(99 %)
0 diff
(100 %id)
BP279961   SLTM.b 1583 to 2184 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
DB044765 testis SLTM.b 1611 to 2147 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DN991640 brain, whole brain SLTM.b 1612 to 2055 33 to 476       444/476
(93 %)
6 diff
(98.8 %id)
DB191960 ovary, tumor tissue SLTM.b 1615 to 2173 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA521467 brain SLTM.b 1618 to 2170 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AW366244 head_neck SLTM.b 1625 to 2036 412 to 1       412/412
(100 %)
8 diff
(98.1 %id)
DA870623 Prostate SLTM.b 1627 to 2162 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
AU135171 placenta SLTM.b 1628 to 2297 2 to 672   capped   671/673
(99 %)
5 diff
(99.3 %id)
CF552374 Pooled muscle (cardiac and skeletal) SLTM.b 1635 to 1903 1 to 269       269/270
(99 %)
3 diff
(98.9 %id)
BC046119 Peripheral Nervous System, sympathetictrunk SLTM.b 1651 to 4108 1 to 2458   available from MGC, AAA   2458/2458
(100 %)
0 diff
(100 %id)
BQ717519 sympathetic trunk SLTM.b 1652 to 2203 1 to 559   available from MGC,   557/1181
(47 %)
19 diff
(98.4 %id)
DN992547 brain, whole brain SLTM.b 1659 to 2215 9 to 565       557/565
(98 %)
6 diff
(99.0 %id)
AA070002   SLTM.b 1660 to 2064 1 to 410       410/415
(98 %)
7 diff
(98.4 %id)
DA276131 corpus callosum SLTM.b 1672 to 2243 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA049230   SLTM.b 1683 to 2286 2 to 605   capped   604/607
(99 %)
1 diff
(99.9 %id)
BE398139 Burkitt lymphoma, lymph SLTM.b 1702 to 2254 54 to 608       557/608
(91 %)
12 diff
(98.1 %id)
CX759013 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SLTM.b 1702 to 2427 1 to 725     Submitted on the opposite strand 725/725
(100 %)
2 diff
(99.8 %id)
BF817097 colon_ins SLTM.b 1713 to 1994 1 to 282       282/282
(100 %)
0 diff
(100 %id)
CV808604 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SLTM.b 1727 to 2464 1 to 738       738/738
(100 %)
1 diff
(99.9 %id)
AU124531   SLTM.b 1746 to 2527 2 to 784   capped   783/783
(100 %)
8 diff
(99.0 %id)
AU125693   SLTM.b 1746 to 2484 2 to 738   capped   737/748
(98 %)
5 diff
(99.4 %id)
AV724833 hypothalamus SLTM.b 1751 to 2451 1 to 699       701/707
(99 %)
8 diff
(98.9 %id)
AW502944 lymph SLTM.b 1771 to 2252 1 to 482       482/482
(100 %)
2 diff
(99.6 %id)
CF143810 lymph SLTM.b 1771 to 2177 1 to 407       407/407
(100 %)
3 diff
(99.3 %id)
CF121483 lymph SLTM.b 1773 to 2287 5 to 520       516/520
(99 %)
7 diff
(98.7 %id)
TI_154158617   SLTM.b 1774 to 2374 76 to 676       601/601
(100 %)
3 diff
(99.6 %id)
TI_154175388   SLTM.b 1774 to 2197 76 to 499       424/424
(100 %)
2 diff
(99.6 %id)
TI_154180585   SLTM.b 1776 to 2575 77 to 882       806/998
(80 %)
26 diff
(97.4 %id)
CN259508 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SLTM.b 1791 to 2373 14 to 597       588/597
(98 %)
7 diff
(98.9 %id)
BF086956 head_neck SLTM.b 1797 to 2355 575 to 21       555/575
(96 %)
2 diff
(99.7 %id)
AW673349 cervix SLTM.b 1801 to 2390 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
AW366252 head_neck SLTM.b 1802 to 2036 1 to 235       235/235
(100 %)
0 diff
(100 %id)
TI_149282168   SLTM.b 1807 to 2451 716 to 72   AAA   645/1109
(58 %)
1 diff
(100.0 %id)
BM983716 lung, Primary Lung Epithelial Cells SLTM.b 1807 to 2451 663 to 19   AAA   645/655
(98 %)
1 diff
(99.9 %id)
W27117 eye, retina SLTM.b 1807 to 2220 435 to 17       419/618
(67 %)
10 diff
(98.4 %id)
BI255138 cervical carcinoma cell line, cervix SLTM.b 1839 to 2589 1 to 751       751/751
(100 %)
4 diff
(99.5 %id)
DA935520 Spleen SLTM.b 1842 to 2445 2 to 606   capped   605/605
(100 %)
1 diff
(99.9 %id)
DA298060 hippocampus SLTM.b 1845 to 2346 2 to 504   capped   503/503
(100 %)
1 diff
(99.9 %id)
BG696062 skin SLTM.b 1859 to 2601 1 to 742       742/742
(100 %)
6 diff
(99.2 %id)
BP336775 coronary artery SLTM.b 1859 to 2455 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BG944776 blood SLTM.b 1860 to 2075 1 to 216   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 216/240
(90 %)
2 diff
(99.2 %id)
AW366253 head_neck SLTM.b 1862 to 2036 175 to 1       175/175
(100 %)
1 diff
(99.5 %id)
CN259502 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLTM.b 1878 to 2616 31 to 769       739/769
(96 %)
10 diff
(98.7 %id)
AU137098 placenta SLTM.b 1880 to 2568 2 to 695   capped   694/699
(99 %)
10 diff
(98.6 %id)
DA310040 hippocampus SLTM.b 1881 to 2430 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BQ224039 embryonal carcinoma, cell line, testis SLTM.b 1885 to 2742 1 to 861       861/903
(95 %)
11 diff
(98.8 %id)
BE297686 muscle, rhabdomyosarcoma SLTM.b 1936 to 2615 25 to 700       676/758
(89 %)
11 diff
(98.6 %id)
BE562358 Burkitt lymphoma, lymph SLTM.b 1936 to 2806 26 to 893       867/947
(91 %)
31 diff
(96.8 %id)
BI227202 Burkitt lymphoma, lymph SLTM.b 1936 to 2746 46 to 861       816/889
(91 %)
25 diff
(97.2 %id)
BM797684 Ascites, stomach SLTM.b 1937 to 2392 1 to 456       456/456
(100 %)
1 diff
(99.8 %id)
BE562357 Burkitt lymphoma, lymph SLTM.b 1948 to 2748 43 to 849       807/1267
(63 %)
33 diff
(97.4 %id)
BI226182 Burkitt lymphoma, lymph SLTM.b 1951 to 2575 1 to 626       626/627
(99 %)
7 diff
(98.9 %id)
AW503636 lymph SLTM.b 1976 to 2445 1 to 470       470/470
(100 %)
5 diff
(99.0 %id)
TI_154159558   SLTM.b 1983 to 2650 93 to 756       664/666
(99 %)
14 diff
(97.9 %id)
BE729699 melanotic melanoma, skin SLTM.b 1992 to 2744 1 to 764       764/1149
(66 %)
33 diff
(97.2 %id)
DA018127 adrenal gland SLTM.b 2001 to 2577 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BE884751 leiomyosarcoma, uterus SLTM.b 2009 to 2667 1 to 660       660/661
(99 %)
10 diff
(98.5 %id)
BF087247 head_neck SLTM.b 2017 to 2369 6 to 350       345/350
(98 %)
7 diff
(98.0 %id)
BF087244 head_neck SLTM.b 2018 to 2369 4 to 354       351/354
(99 %)
6 diff
(98.4 %id)
BP308795 brain SLTM.b 2041 to 2622 1 to 584       584/587
(99 %)
3 diff
(99.5 %id)
AL834297 melanoma (MeWo cell line) SLTM.b 2051 to 3729 1 to 1679   available from DKFZ, AAA   1679/1679
(100 %)
0 diff
(100 %id)
BP342397 stomach mucosa SLTM.b 2089 to 2670 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB201455 trachea SLTM.b 2131 to 2733 2 to 607   capped   604/606
(99 %)
3 diff
(99.6 %id)
BU521691 leiomyosarcoma, uterus SLTM.b 2162 to 3011 1 to 856       856/898
(95 %)
10 diff
(98.9 %id)
AW068568 Bone, Hip SLTM.b 2183 to 2699 10 to 528       519/528
(98 %)
11 diff
(98.0 %id)
BQ216666 large cell carcinoma, lung SLTM.b 2217 to 3109 1 to 893       893/893
(100 %)
14 diff
(98.5 %id)
AU138111 placenta SLTM.b 2219 to 3023 2 to 817   capped   816/821
(99 %)
15 diff
(98.2 %id)
DA276505 corpus callosum SLTM.b 2304 to 2864 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AA342930 Spleen SLTM.b 2305 to 2663 362 to 1       362/367
(98 %)
3 diff
(99.2 %id)
BP193172 brain SLTM.b 2311 to 2891 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BM763021 myeloma SLTM.b 2316 to 2755 1 to 440       440/440
(100 %)
0 diff
(100 %id)
BI008117 kidney_tumor SLTM.b 2334 to 2891 558 to 5       554/558
(99 %)
4 diff
(99.3 %id)
CR988448 T-Lymphocytes SLTM.b 2334 to 3084 1 to 750       750/750
(100 %)
3 diff
(99.6 %id)
BM848661 myeloma SLTM.b 2335 to 2590 1 to 256       256/256
(100 %)
0 diff
(100 %id)
TI_1968235373   SLTM.b 2347 to 3401 1192 to 141       1052/1292
(81 %)
21 diff
(98.4 %id)
BF529337 anaplastic oligodendroglioma with 1p/19qloss, brain SLTM.b 2376 to 3056 25 to 702   AAA   678/940
(72 %)
16 diff
(98.3 %id)
BF954974 nervous_normal SLTM.b 2381 to 2603 17 to 252       236/253
(93 %)
22 diff
(91.4 %id)
BI032989 nervous_normal SLTM.b 2381 to 2846 31 to 494       464/494
(93 %)
8 diff
(98.4 %id)
CR990622 T-Lymphocytes SLTM.b 2383 to 3244 1 to 863       863/863
(100 %)
1 diff
(99.9 %id)
DA910647   SLTM.b 2404 to 2947 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BX284056 skin, squamous cell carcinoma SLTM.b 2422 to 2891 1 to 469       469/475
(98 %)
2 diff
(99.6 %id)
BG681815 skin, squamous cell carcinoma SLTM.b 2422 to 3234 1 to 811       811/811
(100 %)
2 diff
(99.8 %id)
CR985305 T-Lymphocytes SLTM.b 2433 to 3249 1 to 819       819/819
(100 %)
5 diff
(99.4 %id)
DN601877 human embryonic stem cells SLTM.b 2437 to 3120 1 to 683       683/683
(100 %)
1 diff
(99.9 %id)
CV569711 cornea, eye SLTM.b 2440 to 2804 1 to 366       366/366
(100 %)
1 diff
(99.8 %id)
DR423894 eye, Pterygium SLTM.b 2485 to 3274 1 to 788       788/788
(100 %)
9 diff
(98.9 %id)
BX403959 neuroblastoma SLTM.b 2489 to 3561 1 to 1064   fully sequenced,   1064/1064
(100 %)
7 diff
(99.4 %id)
CR613449 neuroblastoma SLTM.b 2489 to 4105 1 to 1617       1617/1617
(100 %)
0 diff
(100 %id)
EB387047 eye, optic nerve SLTM.b 2537 to 3278 1 to 743       743/743
(100 %)
6 diff
(99.2 %id)
AW811788 stomach SLTM.b 2543 to 2641 1 to 100       100/101
(99 %)
2 diff
(98.1 %id)
CX785324 human embryonic stem cells SLTM.b 2543 to 3383 1 to 841       841/841
(100 %)
0 diff
(100 %id)
AW176249 breast SLTM.b 2547 to 2795 255 to 7       249/260
(95 %)
4 diff
(98.5 %id)
BI008852 kidney_tumor SLTM.b 2556 to 2891 13 to 354       342/359
(95 %)
11 diff
(97.0 %id)
BM820515 stomach SLTM.b 2564 to 3103 1 to 540       540/540
(100 %)
0 diff
(100 %id)
BX456513 thymus SLTM.b 2570 to 3473 1 to 902       902/902
(100 %)
3 diff
(99.7 %id)
W26497 eye, retina SLTM.b 2582 to 3052 11 to 480       470/535
(87 %)
9 diff
(98.4 %id)
TI_1968233491   SLTM.b 2586 to 3401 9 to 824       816/1270
(64 %)
7 diff
(99.5 %id)
BF891701 marrow SLTM.b 2609 to 2990 382 to 1     Submitted on the opposite strand 382/397
(96 %)
13 diff
(96.8 %id)
CN259509 embryonic stem cells, cell lines H1, H7, andH9 SLTM.b 2694 to 3249 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BE086766 breast SLTM.b 2725 to 3082 364 to 7     Submitted on the opposite strand 358/365
(98 %)
2 diff
(99.5 %id)
AW364812 denis_drash SLTM.b 2740 to 3419 20 to 703       688/725
(94 %)
56 diff
(92.3 %id)
AL535480 brain, fetal brain SLTM.b 2741 to 3728 1 to 986   fully sequenced,   986/986
(100 %)
2 diff
(99.8 %id)
CR612238 fetal brain SLTM.b 2742 to 3728 1 to 987       987/987
(100 %)
0 diff
(100 %id)
TI_159701389   SLTM.b 2745 to 3460 797 to 85       713/1129
(63 %)
4 diff
(99.7 %id)
BF374901 stomach SLTM.b 2753 to 3374 621 to 1       621/623
(99 %)
8 diff
(98.8 %id)
BP261598 small intestine SLTM.b 2763 to 3345 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP262147 small intestine SLTM.b 2763 to 3336 1 to 573       573/573
(100 %)
3 diff
(99.5 %id)
BF447385 sympathetic trunk SLTM.b 2798 to 3136 339 to 1       339/339
(100 %)
0 diff
(100 %id)
TI_149299871   SLTM.b 2802 to 3731 1017 to 96   AAA   922/993
(92 %)
24 diff
(97.6 %id)
AW793209 uterus SLTM.b 2809 to 3065 9 to 267       259/271
(95 %)
7 diff
(97.5 %id)
BQ331848 lung_tumor SLTM.b 2809 to 2989 1 to 183       183/225
(81 %)
7 diff
(96.9 %id)
FN155294 breast carcinoma SLTM.b 2828 to 2891 1 to 64       64/72
(88 %)
3 diff
(95.9 %id)
BP338096 Spleen SLTM.b 2831 to 3376 1 to 546       546/550
(99 %)
3 diff
(99.5 %id)
BQ376673 uterus SLTM.b 2833 to 3052 1 to 226       226/243
(93 %)
19 diff
(92.2 %id)
BQ423292 embryonal carcinoma, cell line, testis SLTM.b 2841 to 3319 1 to 478       478/569
(84 %)
3 diff
(99.5 %id)
AA974390 pooled germ cell tumors SLTM.b 2843 to 3251 409 to 1       409/409
(100 %)
0 diff
(100 %id)
FN094602 breast carcinoma SLTM.b 2859 to 2955 105 to 9     Submitted on the opposite strand 97/105
(92 %)
0 diff
(100 %id)
AA368344 placenta SLTM.b 2873 to 3165 1 to 294       294/294
(100 %)
1 diff
(99.7 %id)
BQ307794 breast SLTM.b 2890 to 3013 20 to 145       126/145
(86 %)
6 diff
(95.9 %id)
AA300811 testis SLTM.b 2908 to 3142 1 to 235       235/236
(99 %)
1 diff
(99.6 %id)
BE767146 nervous_tumor SLTM.b 2913 to 3384 1 to 483       483/497
(97 %)
41 diff
(91.8 %id)
TI_154090876   SLTM.b 2937 to 3729 884 to 98   AAA   787/867
(90 %)
12 diff
(98.7 %id)
CA434204 lung, Metastatic Chondrosarcoma SLTM.b 2944 to 3729 798 to 19   AAA   780/783
(99 %)
8 diff
(99.0 %id)
BP431384   SLTM.b 2949 to 3240 1 to 292       292/292
(100 %)
2 diff
(99.4 %id)
AA025762 heart SLTM.b 2955 to 3140 1 to 189       189/193
(97 %)
6 diff
(96.9 %id)
AL535479 brain, fetal brain SLTM.b 2957 to 3700 745 to 1   fully sequenced,   745/745
(100 %)
6 diff
(99.2 %id)
AW022933 cochlea, ear SLTM.b 2975 to 3478 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BU685043 lung, Primary Lung Cystic Fibrosis EpithelialCells SLTM.b 2991 to 3731 756 to 17   AAA   740/740
(100 %)
3 diff
(99.6 %id)
CA423421 cell lines, Chondrosarcoma SLTM.b 2991 to 3729 750 to 17   AAA   734/734
(100 %)
10 diff
(98.7 %id)
TI_149290098   SLTM.b 3009 to 3738 796 to 78   AAA   719/797
(90 %)
11 diff
(98.7 %id)
BM973216 lung SLTM.b 3009 to 3738 737 to 19   AAA   719/730
(98 %)
11 diff
(98.5 %id)
BQ001579 lung, Metastatic Chondrosarcoma SLTM.b 3014 to 3735 739 to 19   AAA   721/721
(100 %)
5 diff
(99.4 %id)
BQ015338 Chondrosarcoma, Left Pubic Bone SLTM.b 3020 to 3735 734 to 19   AAA   716/717
(99 %)
5 diff
(99.4 %id)
BF791017 muscle (skeletal) SLTM.b 3022 to 3714 1 to 695       695/899
(77 %)
44 diff
(95.2 %id)
BG428337 Kidney SLTM.b 3022 to 3751 1 to 733       733/935
(78 %)
19 diff
(98.0 %id)
BQ446799 Knee, Osteoarthritic Cartilage SLTM.b 3030 to 3735 724 to 19   AAA   706/706
(100 %)
1 diff
(99.9 %id)
BF028428 bladder, carcinoma, cell line SLTM.b 3047 to 3699 6 to 668       663/1109
(59 %)
38 diff
(96.6 %id)
BQ014402 Chondrosarcoma, Left Pubic Bone SLTM.b 3057 to 3728 690 to 19   AAA   672/676
(99 %)
0 diff
(100 %id)
BG210090   SLTM.b 3068 to 3726 1 to 660       660/795
(83 %)
20 diff
(97.5 %id)
R77384 placenta SLTM.b 3071 to 3490 1 to 424       424/424
(100 %)
5 diff
(98.9 %id)
AV704632 adrenal gland SLTM.b 3080 to 3735 1 to 656       656/719
(91 %)
4 diff
(99.5 %id)
DN917414   SLTM.b 3080 to 3567 1 to 488       488/488
(100 %)
5 diff
(99.0 %id)
CN259504 embryonic stem cells, DMSO-treated H9 cellline SLTM.b 3095 to 3706 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
BM692505 eye, human retina SLTM.b 3102 to 3679 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
BF089829 marrow SLTM.b 3106 to 3422 1 to 320       320/327
(97 %)
13 diff
(96.1 %id)
BF089846 marrow SLTM.b 3106 to 3422 1 to 320       320/327
(97 %)
13 diff
(96.1 %id)
CD693442 normal nasopharynx SLTM.b 3106 to 3682 33 to 609       577/609
(94 %)
6 diff
(99.1 %id)
BP425430 small intestine SLTM.b 3137 to 3643 18 to 525     Submitted on the opposite strand 508/525
(96 %)
6 diff
(98.9 %id)
TI_149286330   SLTM.b 3138 to 4108 1060 to 94   AAA   967/1135
(85 %)
39 diff
(96.6 %id)
BF002482 colon, colon tumor, RER+ SLTM.b 3149 to 3735 598 to 12   AAA   587/587
(100 %)
7 diff
(98.9 %id)
BF681621 Prostate SLTM.b 3155 to 3690 1 to 531       531/756
(70 %)
9 diff
(98.9 %id)
AA356278   SLTM.b 3158 to 3371 1 to 214       214/214
(100 %)
1 diff
(99.6 %id)
CA306946 Alveolar Macrophage, lung SLTM.b 3181 to 3728 566 to 19   AAA   548/548
(100 %)
0 diff
(100 %id)
AU147083 whole embryo, mainly body SLTM.b 3184 to 3728 544 to 1       544/544
(100 %)
9 diff
(98.4 %id)
BF507570   SLTM.b 3191 to 3738 565 to 18   AAA   548/548
(100 %)
1 diff
(99.9 %id)
AU157025 placenta SLTM.b 3201 to 3735 534 to 1       534/538
(99 %)
11 diff
(98.0 %id)
TI_157614260   SLTM.b 3208 to 3731 610 to 87   AAA   524/527
(99 %)
3 diff
(99.5 %id)
AA281405 germinal center B cell SLTM.b 3209 to 3631 1 to 423       423/423
(100 %)
0 diff
(100 %id)
FN059137 breast carcinoma SLTM.b 3213 to 3327 1 to 115       115/115
(100 %)
0 diff
(100 %id)
AA024924 heart SLTM.b 3214 to 3654 1 to 444       444/444
(100 %)
3 diff
(99.4 %id)
AI352698 pooled germ cell tumors SLTM.b 3219 to 3732 518 to 5       514/518
(99 %)
0 diff
(100 %id)
EC577659 Prostate SLTM.b 3220 to 3333 1 to 112       112/112
(100 %)
1 diff
(99.2 %id)
CF528374 placenta SLTM.b 3252 to 3731 495 to 16   AAA   480/480
(100 %)
2 diff
(99.6 %id)
AI005007 pooled SLTM.b 3257 to 3729 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AA910495 leiomyosarcoma, soft tissue SLTM.b 3269 to 3728 464 to 5       460/464
(99 %)
0 diff
(100 %id)
AA025445 heart SLTM.b 3276 to 3730 463 to 7       457/463
(98 %)
0 diff
(100 %id)
TI_149310781   SLTM.b 3281 to 4108 906 to 87   AAA   820/948
(86 %)
14 diff
(98.6 %id)
AI699384 pooled SLTM.b 3294 to 3735 446 to 5       442/446
(99 %)
0 diff
(100 %id)
TI_154113077   SLTM.b 3301 to 4108 884 to 85   AAA   800/915
(87 %)
9 diff
(99.1 %id)
AI741172 pooled SLTM.b 3302 to 3741 443 to 4       440/443
(99 %)
0 diff
(100 %id)
AU155866 placenta SLTM.b 3304 to 3735 432 to 1       432/432
(100 %)
5 diff
(98.9 %id)
TI_151742943   SLTM.b 3306 to 3735 539 to 110   AAA   430/543
(79 %)
0 diff
(100 %id)
AA613320 colon, colon tumor RER+ SLTM.b 3309 to 3735 427 to 1       427/429
(99 %)
0 diff
(100 %id)
AW341946 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus SLTM.b 3313 to 3731 419 to 1       419/419
(100 %)
0 diff
(100 %id)
W56714 heart SLTM.b 3316 to 3676 1 to 364       364/434
(83 %)
8 diff
(98.2 %id)
AA587698 colon, colon tumor RER+ SLTM.b 3332 to 3735 404 to 1       404/404
(100 %)
0 diff
(100 %id)
BF593573 Kidney SLTM.b 3342 to 3735 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI753962 bone marrow stroma SLTM.b 3346 to 3735 410 to 21   AAA   390/390
(100 %)
0 diff
(100 %id)
AA336135 epididymis SLTM.b 3356 to 3659 1 to 308       308/308
(100 %)
6 diff
(98.1 %id)
FN171069 breast carcinoma SLTM.b 3359 to 3438 1 to 79       79/79
(100 %)
4 diff
(95.0 %id)
AW166224 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SLTM.b 3387 to 3729 361 to 19   AAA   343/343
(100 %)
5 diff
(98.6 %id)
DW446426 Liver SLTM.b 3388 to 3588 17 to 217       201/217
(92 %)
6 diff
(97.3 %id)
FN166966 breast carcinoma SLTM.b 3388 to 3494 1 to 110       110/110
(100 %)
3 diff
(97.3 %id)
AA846058 Spleen SLTM.b 3406 to 3732 330 to 4       327/330
(99 %)
0 diff
(100 %id)
AW797302 uterus SLTM.b 3436 to 3630 1 to 192       192/192
(100 %)
8 diff
(95.9 %id)
AU253295 neuroblastoma SLTM.b 3436 to 4114 700 to 23   tiling clone, AAA   678/678
(100 %)
3 diff
(99.6 %id)
AW797305 uterus SLTM.b 3442 to 3731 28 to 317       290/326
(88 %)
3 diff
(99.1 %id)
AI696439 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus SLTM.b 3486 to 3735 251 to 1       251/251
(100 %)
6 diff
(97.7 %id)
AI680379 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus SLTM.b 3522 to 3735 215 to 2       214/215
(99 %)
0 diff
(100 %id)
AI206687 lung SLTM.b 3523 to 3732 211 to 2       210/211
(99 %)
0 diff
(100 %id)
BX454006 neuroblastoma SLTM.b 3531 to 4103 589 to 4   fully sequenced,   586/589
(99 %)
17 diff
(97.2 %id)
AU149300   SLTM.b 3535 to 4108 570 to 1       570/575
(99 %)
21 diff
(96.4 %id)
FN135450 breast carcinoma SLTM.b 3542 to 3647 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
AU154446   SLTM.b 3549 to 4108 560 to 1       560/560
(100 %)
7 diff
(98.8 %id)
BM983311 lung, Primary Lung Epithelial Cells SLTM.b 3550 to 3731 198 to 17   AAA   182/182
(100 %)
0 diff
(100 %id)
AU157475 placenta SLTM.b 3554 to 4108 555 to 2       554/557
(99 %)
0 diff
(100 %id)
DB362417   SLTM.b 3564 to 4108 547 to 1       547/553
(98 %)
22 diff
(96.1 %id)
FN161515 breast carcinoma SLTM.b 3573 to 3672 1 to 96       96/96
(100 %)
4 diff
(95.9 %id)
AW263634 pooled SLTM.b 3717 to 4109 393 to 1       393/393
(100 %)
10 diff
(97.5 %id)
BU733012 eye, human retina SLTM.b 3718 to 4107 408 to 19   AAA   390/390
(100 %)
1 diff
(99.8 %id)
AW022552 cochlea, ear SLTM.b 3728 to 4108 1 to 381   AAA   381/381
(100 %)
5 diff
(98.7 %id)
AW168707 bowel (skin primary), metastatic melanoma to bowel SLTM.b 3747 to 4108 367 to 1       367/371
(98 %)
11 diff
(97.1 %id)
CB050724 Prostate SLTM.b 3748 to 4108 404 to 44   AAA   361/373
(96 %)
8 diff
(97.9 %id)
BG055161 Prostate SLTM.b 3761 to 4108 349 to 1       349/349
(100 %)
1 diff
(99.8 %id)
AA779624   SLTM.b 3807 to 4028 222 to 1       222/222
(100 %)
0 diff
(100 %id)
AA069833   SLTM.b 3838 to 4110 277 to 1       277/278
(99 %)
5 diff
(98.3 %id)
AI524584 serous papillary carcinoma, high grade, 2pooled tumors, uterus SLTM.b 3858 to 4110 253 to 1       253/253
(100 %)
2 diff
(99.3 %id)
FN057546 breast carcinoma SLTM.b 3866 to 3965 1 to 99       99/100
(99 %)
4 diff
(96.0 %id)
AI970970 Prostate SLTM.b 3866 to 4110 248 to 4       245/248
(98 %)
0 diff
(100 %id)
AI201968 Prostate SLTM.b 3868 to 4108 258 to 18   AAA   241/241
(100 %)
0 diff
(100 %id)
AI475708 B-cell, chronic lymphotic leukemia SLTM.b 3870 to 4102 239 to 7       233/239
(97 %)
0 diff
(100 %id)
AI383388 B-cell, chronic lymphotic leukemia SLTM.b 3878 to 4107 232 to 3       230/232
(99 %)
0 diff
(100 %id)
AI271961 Kidney SLTM.b 3926 to 4108 195 to 13   AAA   183/183
(100 %)
2 diff
(99.0 %id)
AA999713 Kidney SLTM.b 3943 to 4108 193 to 28   AAA   166/166
(100 %)
1 diff
(99.4 %id)
FN141750 breast carcinoma SLTM.b 4005 to 4065 1 to 61       61/65
(93 %)
2 diff
(97.0 %id)
AK291423 brain SLTM.c 1 to 3021 1 to 3021 exact tiling clone,   3021/3021
(100 %)
2 diff
(100.0 %id)
DC376973 brain SLTM.c 1 to 559 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
DC347539 tongue, tumor tissue SLTM.c 21 to 596 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
DC336665 substantia nigra SLTM.c 32 to 617 1 to 586       586/586
(100 %)
0 diff
(100 %id)
CD655456 Embryonic Stem cells SLTM.c 233 to 941 12 to 712       701/803
(87 %)
23 diff
(97.2 %id)
CR977571 T-Lymphocytes SLTM.c 268 to 1163 1 to 892       892/897
(99 %)
5 diff
(99.5 %id)
AW960631   SLTM.c 2799 to 3286 1 to 488       488/488
(100 %)
8 diff
(98.4 %id)
CA448678 Chondrosarcoma, Left Pelvis SLTM.c 2801 to 3529 747 to 19   tiling clone, AAA   729/729
(100 %)
0 diff
(100 %id)
TI_151705663   SLTM.c 2805 to 3528 803 to 79   AAA   725/1188
(61 %)
31 diff
(97.4 %id)
AA491094 germinal center B cell SLTM.c 2829 to 3211 1 to 383   fully sequenced,   383/383
(100 %)
0 diff
(100 %id)
BU689049 lung SLTM.c 2852 to 3529 696 to 19   AAA   678/678
(100 %)
0 diff
(100 %id)
BM971934 lung SLTM.c 2858 to 3529 689 to 19   AAA   671/671
(100 %)
1 diff
(99.9 %id)
W37126 parathyroid gland, parathyroid tumor SLTM.c 2859 to 3312 15 to 477       463/477
(97 %)
6 diff
(98.8 %id)
AA479225 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLTM.c 2905 to 3326 1 to 422       422/422
(100 %)
0 diff
(100 %id)
AW873568 pooled SLTM.c 2912 to 3529 618 to 1       618/618
(100 %)
1 diff
(99.9 %id)
R33378 placenta SLTM.c 2932 to 3270 1 to 341   fully sequenced,   341/341
(100 %)
19 diff
(94.5 %id)
AA524709 colon SLTM.c 2955 to 3531 579 to 1       579/579
(100 %)
17 diff
(97.1 %id)
AA521008 germinal center B cell SLTM.c 2970 to 3529 589 to 33   AAA   557/560
(99 %)
23 diff
(95.9 %id)
AA534715 colon SLTM.c 2974 to 3529 556 to 1       556/556
(100 %)
3 diff
(99.5 %id)
AI378568 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLTM.c 2991 to 3531 548 to 8       541/548
(98 %)
0 diff
(100 %id)
AW338906 adenocarcinoma, Pancreas SLTM.c 3014 to 3530 517 to 1       517/517
(100 %)
0 diff
(100 %id)
AA923147 carcinoid, lung SLTM.c 3020 to 3531 513 to 2       512/513
(99 %)
0 diff
(100 %id)
TI_154134296   SLTM.c 3020 to 3537 620 to 93       528/944
(55 %)
0 diff
(100 %id)
BP419748 small intestine SLTM.c 3024 to 3429 1 to 412     Submitted on the opposite strand 412/412
(100 %)
8 diff
(98.1 %id)
AA843489 parathyroid gland, parathyroid tumor SLTM.c 3034 to 3531 504 to 7       498/504
(98 %)
0 diff
(100 %id)
AW205445   SLTM.c 3037 to 3529 513 to 18   AAA   496/506
(98 %)
3 diff
(99.5 %id)
BF477767 Prostate SLTM.c 3042 to 3529 499 to 12   AAA   488/488
(100 %)
0 diff
(100 %id)
AA480074 ovarian tumor, ovary SLTM.c 3050 to 3529 1 to 480   AAA   480/480
(100 %)
0 diff
(100 %id)
AI818317 adenocarcinoma, Pancreas SLTM.c 3058 to 3529 484 to 13   AAA   472/472
(100 %)
0 diff
(100 %id)
AI917075 pooled germ cell tumors SLTM.c 3064 to 3531 471 to 4       468/471
(99 %)
0 diff
(100 %id)
AA845581 parathyroid gland, parathyroid tumor SLTM.c 3065 to 3531 472 to 6       467/472
(98 %)
0 diff
(100 %id)
BF115803 carcinoid, lung SLTM.c 3071 to 3531 462 to 2       461/462
(99 %)
0 diff
(100 %id)
BG337808 leiomyosarcoma cell line, uterus SLTM.c 3074 to 3529 1 to 458       458/1006
(45 %)
11 diff
(99.0 %id)
AI082786 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLTM.c 3075 to 3529 475 to 21   AAA   455/455
(100 %)
0 diff
(100 %id)
BE407699 choriocarcinoma, placenta SLTM.c 3077 to 3527 9 to 458       450/458
(98 %)
6 diff
(98.7 %id)
W79359 heart SLTM.c 3081 to 3446 4 to 377       374/414
(90 %)
6 diff
(98.6 %id)
AI191661 heart SLTM.c 3081 to 3531 453 to 3       451/453
(99 %)
0 diff
(100 %id)
AI524183 B-cell, chronic lymphotic leukemia SLTM.c 3083 to 3531 451 to 3       449/451
(99 %)
0 diff
(100 %id)
AA642699 normal prostate, Prostate SLTM.c 3087 to 3529 443 to 1       443/443
(100 %)
0 diff
(100 %id)
BF224323 carcinoid, lung SLTM.c 3090 to 3531 447 to 6       442/447
(98 %)
0 diff
(100 %id)
AA479070.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLTM.c 3092 to 3529 451 to 14   AAA also hits gene KDM1B 438/438
(100 %)
0 diff
(100 %id)
N68036 cochlea, ear SLTM.c 3100 to 3531 433 to 1       433/433
(100 %)
1 diff
(99.8 %id)
AI804074 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SLTM.c 3100 to 3531 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI289853 2 pooled tumors (clear cell type), Kidney SLTM.c 3102 to 3531 431 to 2       430/431
(99 %)
0 diff
(100 %id)
AI039641   SLTM.c 3107 to 3531 427 to 2       426/427
(99 %)
0 diff
(100 %id)
AI033327 liver and spleen SLTM.c 3111 to 3529 419 to 1       419/423
(99 %)
0 diff
(100 %id)
AI289627 serous papillary carcinoma, high grade, 2pooled tumors, uterus SLTM.c 3111 to 3529 417 to 1       417/418
(99 %)
2 diff
(99.6 %id)
AI694756 carcinoid, lung SLTM.c 3123 to 3528 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
AI694010 colon SLTM.c 3128 to 3531 405 to 2       404/405
(99 %)
0 diff
(100 %id)
AI874195 serous papillary carcinoma, high grade, 2pooled tumors, uterus SLTM.c 3132 to 3529 415 to 18   AAA   398/398
(100 %)
3 diff
(99.3 %id)
AI192133 uterus SLTM.c 3139 to 3531 398 to 6       393/398
(98 %)
0 diff
(100 %id)
AI745094 ovary, tumor, 5 pooled (see description) SLTM.c 3140 to 3535 414 to 19   tiling clone, AAA   396/396
(100 %)
0 diff
(100 %id)
AW137832   SLTM.c 3145 to 3529 403 to 18   AAA   386/386
(100 %)
3 diff
(99.3 %id)
AA490907 germinal center B cell SLTM.c 3181 to 3529 381 to 33   fully sequenced, AAA   349/349
(100 %)
0 diff
(100 %id)
R33379 placenta SLTM.c 3241 to 3513 288 to 11   fully sequenced,   278/288
(96 %)
0 diff
(100 %id)
AK055195 tongue, tumor tissue SLTM.d 1 to 3022 1 to 3022   tiling clone, available from FLJ,   3022/3022
(100 %)
0 diff
(100 %id)
DA435639 tongue, tumor tissue SLTM.d 2 to 582 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
AW594341 pooled germ cell tumors SLTM.d 126 to 387 262 to 1       262/262
(100 %)
0 diff
(100 %id)
CR976489 T-Lymphocytes SLTM.d 330 to 1206 1 to 875       875/875
(100 %)
4 diff
(99.6 %id)
AW188258 pooled SLTM.d 341 to 847 507 to 1       507/507
(100 %)
0 diff
(100 %id)
DB313374 tongue, tumor tissue SLTM.d 2485 to 3022 538 to 1       538/538
(100 %)
0 diff
(100 %id)
DA797023 brain SLTM.e 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
DA735986   SLTM.e 318 to 1046 2 to 730   capped   729/734
(99 %)
4 diff
(99.5 %id)
CN259507 embryonic stem cells, DMSO-treated H9 cellline SLTM.e 405 to 1092 1 to 688       688/688
(100 %)
5 diff
(99.3 %id)
BC040120 Cervix, carcinoma SLTM.e 429 to 2808 1 to 2380   tiling clone, available from MGC, AAA   2380/2380
(100 %)
1 diff
(100.0 %id)
BI259811 cervical carcinoma cell line, cervix SLTM.e 429 to 1202 1 to 772   available from MGC,   772/772
(100 %)
6 diff
(99.3 %id)
BI259719 cervical carcinoma cell line, cervix SLTM.e 429 to 1091 1 to 662       662/662
(100 %)
1 diff
(99.9 %id)
BE766265 nervous_tumor SLTM.e 537 to 919 27 to 408       382/408
(93 %)
9 diff
(97.8 %id)
DA635999 Kidney SLTM.e 672 to 1259 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
BQ352417 head_neck SLTM.e 736 to 918 14 to 198       185/205
(90 %)
13 diff
(93.7 %id)
AU153088   SLTM.e 2306 to 2808 504 to 1       504/528
(95 %)
8 diff
(98.5 %id)
DA945510 Spleen SLTM.f 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
DB074304 testis SLTM.f 303 to 843 2 to 544   tiling clone, capped   543/543
(100 %)
2 diff
(99.7 %id)
BX488892   SLTM.f 688 to 1354 1 to 671   tiling clone,   671/673
(99 %)
8 diff
(98.9 %id)
DB333485 Spleen SLTM.f 2027 to 2595 569 to 1   tiling clone,   569/569
(100 %)
2 diff
(99.7 %id)
DA786868 brain SLTM.g 1 to 579 7 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
DB092471 testis SLTM.g 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
BE772220 prostate_tumor SLTM.g 179 to 575 402 to 2       401/402
(99 %)
0 diff
(100 %id)
BE772291 prostate_tumor SLTM.g 217 to 601 396 to 13       384/396
(96 %)
0 diff
(100 %id)
BX642269   SLTM.g 380 to 1039 1 to 660   tiling clone,   660/668
(98 %)
1 diff
(99.9 %id)
AK131242 caudate nucleus SLTM.h 1 to 2280 1 to 2282 D73G E115G G116S S117L L118A ... tiling clone, available from FLJ,   2285/2282
(100 %)
6 diff
(99.8 %id)
BX485104   SLTM.h 542 to 1017 1 to 476       476/476
(100 %)
0 diff
(100 %id)
BF926199 nervous_tumor SLTM.h 681 to 911 255 to 25     Submitted on the opposite strand 231/255
(90 %)
0 diff
(100 %id)
BE817442 breast_normal SLTM.h 1145 to 1465 8 to 327       320/327
(97 %)
8 diff
(97.6 %id)
BE817674 breast_normal SLTM.h 1151 to 1721 12 to 583       572/583
(98 %)
6 diff
(99.0 %id)
BE817630 breast_normal SLTM.h 1369 to 1731 376 to 11   tiling clone,   366/376
(97 %)
0 diff
(100 %id)
BE817650 breast_normal SLTM.h 1369 to 1731 380 to 11   tiling clone,   370/380
(97 %)
0 diff
(100 %id)
DA252581 caudate nucleus SLTM.i 1 to 591 2 to 592   tiling clone, capped   591/591
(100 %)
1 diff
(99.9 %id)
DB306423 caudate nucleus SLTM.i 1730 to 2276 548 to 1   tiling clone,   548/548
(100 %)
1 diff
(99.9 %id)
BQ434991 eye, retinoblastoma SLTM.j 1 to 930 5 to 943 A2S L208V W209M K210E S211E ... tiling clone,   939/943
(99 %)
40 diff
(95.8 %id)
DA854659 placenta SLTM.k 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
BQ771790 Chondrosarcoma Grade II, Left Pelvis SLTM.k 42 to 761 722 to 3   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 720/722
(99 %)
0 diff
(100 %id)
CD514157 brain, Pituitary SLTM.k 653 to 1407 8 to 765       760/906
(83 %)
17 diff
(98.2 %id)
BE147903 head_neck SLTM.k 690 to 1344 58 to 722       673/722
(93 %)
34 diff
(95.3 %id)
CB853565 Human Lung Epithelial cells, lung SLTM.k 706 to 1472 24 to 789   tiling clone, Submitted on the opposite strand 766/789
(97 %)
6 diff
(99.3 %id)
DA930741 small intestine SLTM.k 832 to 1382 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DA895485 skeletal muscle SLTM.k 968 to 1535 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
BP320203 placenta SLTM.k 988 to 1569 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CU447586 epidermis SLTM.k 1078 to 1723 737 to 91     Submitted on the opposite strand 647/737
(87 %)
2 diff
(99.8 %id)
CU449258 epidermis SLTM.k 1100 to 1723 715 to 91   tiling clone, Submitted on the opposite strand 625/715
(87 %)
0 diff
(100 %id)
CD644297 Embryonic Stem cells SLTM.k 1371 to 2176 11 to 816   tiling clone,   806/816
(98 %)
16 diff
(98.1 %id)
BI545681 brain, hippocampus SLTM.l 1 to 723 1 to 724 E190D E191G E192R E193R N194K ... tiling clone,   724/724
(100 %)
6 diff
(99.2 %id)
TI_44166141   SLTM.l 7 to 723 129 to 846 E190D E191G E192R E193R N194K ...     718/846
(84 %)
7 diff
(99.2 %id)
CD688133 normal nasopharynx SLTM.m 1 to 499 24 to 522 C2G tiling clone,   502/522
(96 %)
6 diff
(98.9 %id)
BP310761 brain SLTM.n 1 to 594 1 to 594 exact tiling clone,   594/594
(100 %)
1 diff
(99.9 %id)
BX485300   SLTM.o 1 to 691 1 to 690 C2G K5R M6W A7L A8P ... tiling clone,   690/690
(100 %)
5 diff
(99.3 %id)
CN259503 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SLTM.p 1 to 334 1 to 334 exact tiling clone,   334/334
(100 %)
0 diff
(100 %id)
AW837822 leiomios SLTM.q 1 to 342 340 to 1   tiling clone,   340/349
(97 %)
13 diff
(96.3 %id)
AI652768 pooled germ cell tumors SLTM.q 274 to 918 643 to 1   tiling clone,   643/643
(100 %)
8 diff
(98.8 %id)
AI962572 pooled germ cell tumors SLTM.r 1 to 402 1 to 402 exact tiling clone, Submitted on the opposite strand 402/402
(100 %)
0 diff
(100 %id)
AI961016 pooled germ cell tumors SLTM.r 6 to 510 1 to 505   tiling clone, Submitted on the opposite strand 505/505
(100 %)
3 diff
(99.5 %id)
DA106067 cerebellum SLTM.s 1 to 550 2 to 551 exact tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
CN289658 embryonic stem cells, DMSO-treated H9 cellline SLTM.s 456 to 961 1 to 506   tiling clone,   506/506
(100 %)
1 diff
(99.9 %id)
BQ009455 Chondrosarcoma, Left Pubic Bone SLTM.t 1 to 674 691 to 19 E21N R22A H23M G24D R25X ... tiling clone, AAA   673/673
(100 %)
1 diff
(99.9 %id)
BG619357 placenta SLTM.u-u 1 to 806 1 to 805 exact tiling clone,   805/846
(95 %)
25 diff
(97.1 %id)
CF455815 peripheral nervous system SLTM.u-u 14 to 1093 1 to 1088 exact tiling clone,   1088/1106
(98 %)
20 diff
(98.2 %id)
AL589514 human spinal cord SLTM.va-u 1 to 388 27 to 414 exact tiling clone,   388/414
(93 %)
6 diff
(98.6 %id)
BU568266 testis SLTM.va-u 137 to 948 1 to 808   tiling clone,   808/809
(99 %)
8 diff
(99.1 %id)
BU852337 testis SLTM.va-u 137 to 915 1 to 781   tiling clone,   781/782
(99 %)
10 diff
(98.8 %id)
AW590810 pooled germ cell tumors SLTM.vb 1 to 438 438 to 1   tiling clone,   438/438
(100 %)
1 diff
(99.8 %id)
AW590791 pooled germ cell tumors SLTM.vb 116 to 438 323 to 1       323/323
(100 %)
1 diff
(99.7 %id)
BF903984 marrow SLTM.vb 351 to 922 580 to 5 K52N G54R I55N P56S tiling clone, Submitted on the opposite strand 576/594
(96 %)
2 diff
(99.7 %id)
CN259506 embryonic stem cells, cell lines H1, H7, andH9 SLTM.vc-u 1 to 688 1 to 687 R30Q tiling clone,   687/687
(100 %)
2 diff
(99.8 %id)
BF903884 marrow SLTM.vc-u 468 to 634 166 to 1     Submitted on the opposite strand 166/166
(100 %)
5 diff
(97.0 %id)
DA191398 amygdala SLTM.vd 1 to 612 2 to 613   tiling clone, capped   612/612
(100 %)
0 diff
(100 %id)
AL601692   SLTM.ve 1 to 604 1 to 605 V7G S25F V26C E27* tiling clone,   605/606
(99 %)
3 diff
(99.6 %id)
DW423445 Liver SLTM.ve 134 to 415 10 to 291       282/291
(96 %)
6 diff
(98.0 %id)
DA759236   SLTM.vf 1 to 529 2 to 531 A2V R36X R37A N38E D40R ... tiling clone, capped   530/530
(100 %)
4 diff
(99.3 %id)
AU185017 skin SLTM.vg-u 1 to 412 1 to 412 L2F tiling clone,   412/412
(100 %)
1 diff
(99.8 %id)
FN134244 breast carcinoma SLTM.vi-u 1 to 76 1 to 76 exact tiling clone,   76/76
(100 %)
3 diff
(96.1 %id)
FN171113 breast carcinoma SLTM.vi-u 1 to 76 1 to 74 exact     74/74
(100 %)
5 diff
(93.3 %id)
GD152779   SLTM.vi-u 20 to 107 1 to 87   tiling clone, AAA   87/87
(100 %)
5 diff
(94.3 %id)
CV574008 cornea, eye Gene SLTM, variant not shown         Suspected internal deletion, this clone was ignored    
BF814734 colon_ins Gene SLTM, variant not shown         Suspected internal deletion, this clone was ignored    
BF830571 head_neck Gene SLTM, variant not shown         Suspected internal deletion, this clone was ignored    
M86142   Gene SLTM, variant not shown         This clone was ignored    
DB124910 thymus Gene SLTM, variant not shown       capped      
DB344212 thymus Gene SLTM, variant not shown              
BE167466 head_neck Gene SLTM, variant not shown              
AW379046 head_neck Gene SLTM, variant not shown         Suspected internal deletion, this clone was ignored    
DB253100 uterus Gene SLTM, variant not shown       capped      
DB351222 uterus Gene SLTM, variant not shown              
DA069268 cerebellum Gene SLTM, variant not shown       capped      
AA505004   Gene SLTM, variant not shown         This clone was ignored    
AA505005   Gene SLTM, variant not shown         This clone was ignored    
BG829228 muscle, rhabdomyosarcoma Gene SLTM, variant not shown         Suspected internal deletion, this clone was ignored    
CX786417 human embryonic stem cells Gene SLTM, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u-u, .va-u, .vb, .vc-u, .vd, .ve, .vf, .vg-u, .vh-u, .vi-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C